Insomnia s Negative Sequelae On Mood from Neuroscience to Intervention in the A...
Insomnia s Negative Sequelae On Mood from Neuroscience to Intervention in the Aged
Major depression is among the most burdening health hazards. Its prevalence is 1-3%, an additional 8-16% have clinically significant symptoms, and prognosis is poor. Unfortunately, less than 20% of the cases are detected and treat...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2017-85310-R
EFECTOS DE LA CONCENTRACION DE BETA AMILOIDE CEREBRAL SOBRE...
121K€
Cerrado
PID2020-118825GB-I00
LA INFLAMACION DEL TEJIDO ADIPOSO Y LA CAPACIDAD CARDIORRESP...
73K€
Cerrado
PID2019-107286RB-I00
PAPEL DEL ANTAGONISTA DE RECEPTORES DE MUERTE, FAIM-L EN LA...
167K€
Cerrado
ORACLE
Origins of Alzheimer s disease across the life course
1M€
Cerrado
PSI2008-00850
PREDICTORES PSICOLOGICOS DE DETERIORO COGNITIVO Y DEPENDENCI...
69K€
Cerrado
RYC-2017-22666
Mecanismos y dianas terapéuticas en las alteraciones emocion...
309K€
Cerrado
Información proyecto INSOMNIA
Duración del proyecto: 72 meses
Fecha Inicio: 2015-10-13
Fecha Fin: 2021-10-31
Descripción del proyecto
Major depression is among the most burdening health hazards. Its prevalence is 1-3%, an additional 8-16% have clinically significant symptoms, and prognosis is poor. Unfortunately, less than 20% of the cases are detected and treatment effectiveness is moderate. The Global Consortium for Depression Prevention stresses that our best chance to combat the global burden of depression is provide preventive intervention to identified people at risk. This project targets the strongest modifiable risk factor: insomnia.
With prevalence estimates up to 40%, insomnia is among the most frequent disorders in the elderly population. Meta-analysis shows that no less than 13% of people with insomnia develop depression. This extreme risk and the very high prevalence of insomnia in the ageing population, shows the urgency and promise of: (1) early identification of these 13%, (2) finding mechanisms by quantification of how they differ from insomniacs that do not develop depression with respect to brain structure and function, psychological traits, behavioural habits and environmental exposures; and (3) enrolling them in intervention protocols aimed at sleep improvement and prevention of depression.
The project extends recent findings emerging from the applicant’s pioneering, unconventional and innovative approach to insomnia; the proposal that distinct subtypes exist and can be discriminated data-driven by means of multivariate trait analysis and brain imaging. Ignorance of this heterogeneity has obstructed progress in mechanistic understanding and rational treatment. In an unprecedented interdisciplinary way the project (1) identifies the insomnia subtype that develops depression; (2) profiles mechanisms involved; and (3) optimizes effectiveness of internet-supported home-applicable interventions to improve sleep and prevent depression. This approach will identify risks and mechanisms, and facilitate immediate implementation of risk-based prevention strategies and policies.